Viracta Therapeutics Announces First Clinical Response in Epstein-Barr Virus-Positive (EBV+) Solid Tumor Setting and Outlines Key 2023 Clinical Objectives
Partial response (PR) observed in third dose level of the Phase 1b dose escalation study…
News
PoliMOVE Wins the Autonomous Challenge @ CES 2023, Setting a New Autonomous Speed World Record for a Racetrack
LAS VEGAS–(BUSINESS WIRE)–#IAC2022–The Indy Autonomous Challenge (IAC) team PoliMOVE from Politecnico di Milano (Italy), and…
CymaBay Therapeutics Announces Collaboration with Kaken Pharmaceutical Co., Ltd. to Develop and Commercialize Seladelpar in Japan for Primary Biliary Cholangitis
Advances strategy to partner seladelpar for PBC outside U.S. Brings in approximately $34.0 million upfront…
Annexon Highlights Strategic Focus to Advance Four Flagship Complement Programs through Late-Stage Development and Progress Across Three Therapeutic Franchises
Mid-stage and Pivotal Trials of ANX005, ANX007 and ANX1502 Poised to Achieve Numerous Catalysts in…
Viridian Announces Positive Data from Ongoing Phase 1/2 Trial Evaluating Low Dose VRDN-001 in Patients with Thyroid Eye Disease (TED)
– Significant and rapid improvement in both signs and symptoms of TED after two infusions…
MetaMan Acquires Drip Project for 1 Million US Dollars
Mumbai, India–(Newsfile Corp. – January 8, 2023) – MetaMan announced the acquisition of new-gen luxury…
Sell Bitcoin Dubai Becomes the Top Crypto OTC Since the Launch
Dubai, United Arab Emirates–(Newsfile Corp. – January 7, 2023) – Sell Bitcoin in Dubai becomes…
Fame Global (FAMEG) Is Now Available for Trading on LBank Exchange
Internet City, Dubai–(Newsfile Corp. – January 7, 2023) – LBank Exchange, a global digital asset…
UEI Expands Its Wireless Connectivity Solutions With Enhanced Security, Sustainability, and Scalability
LAS VEGAS–(BUSINESS WIRE)–$UEIC #CE—Universal Electronics Inc. (UEI) (NASDAQ: UEIC), the global leader in wireless universal…
Pertamina International Shipping (PIS) Secures Collaboration Agreements with Global Partners
JAKARTA, Jan 7, 2023 – (ACN Newswire) – PT Pertamina International Shipping (PIS) has secured…
OpGen Announces Pricing of $7.5 Million Public Offering
ROCKVILLE, Md., Jan. 06, 2023 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the…
XOMA Announces New Employment Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
EMERYVILLE, Calif., Jan. 06, 2023 (GLOBE NEWSWIRE) — XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the…
Singapore Property Agency Realty ONE Group Life Style Hires Derek Lee as KEO
Singapore luxury and HDB real estate agency Realty ONE Group Life Style welcomes Derek Lee…
GWH, GWH.WT EQUITY ALERT: ROSEN, A LEADING NATIONAL FIRM, Encourages ESS Tech, Inc. Investors to Inquire About Securities Class Action Investigation – GWH, GWH.WT
NEW YORK–(BUSINESS WIRE)–WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation…
Perma-Pipe International Holdings Inc. announces the formation of a Joint Venture in The Kingdom of Saudi Arabia
SPRING, Texas–(BUSINESS WIRE)–Perma-Pipe International Holdings, Inc. (Nasdaq: PPIH) has entered into a joint venture with…
LTC Senior Management to Participate in the 3rd Annual Capital One Securities Virtual REIT Conference
WESTLAKE VILLAGE, Calif.–(BUSINESS WIRE)–LTC Properties Inc. (NYSE: LTC), a real estate investment trust that invests…
Broadband Subsidiary of Boston Omaha Corporation Announces Frank DeJoy as Chief Operating Officer
OMAHA, Neb.–(BUSINESS WIRE)–Boston Omaha Broadband, a national broadband provider, has named Frank DeJoy as Chief…
BioAegis Leverages Gelsolin’s Broad Therapeutic Applicability by Expanding into Multiple Inflammatory Diseases
Company directs clinical effort of its breakthrough therapy to Acute Respiratory Distress Syndrome, for which…
LAVA Therapeutics Announces Appointment of New Directors to the Board
Peter A. Kiener, DPhil and Mary E. Wadlinger to Join LAVA Board UTRECHT, The Netherlands…
Amolyt Pharma Announces $138 Million Series C Financing led by Sofinnova Partners and co-led by Intermediate Capital Group
Funds will be used to complete phase 3 clinical development of eneboparatide (AZP-3601) for hypoparathyroidism,…